Global Biobanking Market PPT: Demand, Trends and Business Opportunities 2022-27

1
Global Biobanking Market Research and Forecast
Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Biobanking Market Research Report
2022-2027 According to the latest report by
IMARC Group, titled "Biobanking Market Global
Industry Trends, Share, Size, Growth, Opportunity
and Forecast 2022-2027," the global biobanking
market size reached US 53.3 Billion in 2021.
Biobanking refers to the procedure of
collecting and preserving human biospecimens that
can be further used for diagnosis, biodiversity
studies, and research. These specimens are stored
for several years and are used by multiple
researchers for cross-purpose research studies
and to improve the understanding of health and
different diseases. Over the years, biobanking
has become a vital resource in medical research,
supporting various types of contemporary research
like genomics and personalized medicine. Request
for a PDF sample of this report
https//www.imarcgroup.com/biobanking-market/reque
stsample

4
Report Description and Highlights
Report Description
Global Biobanking Market Trends The market is
primarily driven by the growing prevalence of
infectious and chronic diseases as biobanking is
extensively used to develop diagnostics that can
accurately and quickly identify pathogens. In
addition, the escalating demand for regenerative
medicine and personalized treatment represents
another major growth-inducing factor. Besides
this, health agencies of numerous countries are
investing in virtual biobank network models that
help investigators locate biospecimens and data
mining from multiple biobanks. This, coupled with
the significant developments in genomics, disease
biology, metagenomics, proteomics, bioenergy, and
environmental remediation, are positively
influencing the market growth. Moreover, key
players are integrating various advanced
technologies with biobanking that assists
healthcare professionals in collecting
high-quality and well-annotated human
biospecimens, and understanding pathogenic
mechanisms. These advanced methods are also being
utilized to identify therapeutic targets of
coronavirus disease (COVID-19), which is also
creating a positive market outlook across the
globe. Looking forward, IMARC Group expects the
market to reach US 77.6 Billion by 2027,
expanding at a CAGR of 6.18 during the forecast
period (2022-2027). View Report TOC, Figures and
Tables https//www.imarcgroup.com/biobanking-mark
et

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Specimen Type
• Blood Products
• Solid Tissue
• Cell Lines
• Nucleic Acid
• Others
•  
• Breakup by Biobank Type
• Population-based Biobanks
• Disease-oriented Biobanks
• Breakup by Application
• Therapeutics
• Research

6
Report Description and Highlights
Report Description

• Breakup by End User
• Academic Institutions
• Pharma and Biotech Companies
•  
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

7
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• Brooks Automation Inc
• Bay Biosciences LLC
• Boca Biolistics
• Ctibiotech
• Cureline Inc
• Firalis
• Greiner Bio-One International GmbH
• Hamilton Company
• Merck KGaA
• ProteoGenex Inc
• Thermo Fisher Scientific Inc
• VWR Corporation (Avantor Inc.)
•  

8
Key Questions Answered in the Report
Report Description

• What was the size of the global biobanking market
  in 2021?
• What is the expected growth rate of the global
  biobanking market during 2022-2027?
• What are the key factors driving the global
  biobanking market?
• What has been the impact of COVID-19 on the
  global biobanking market?
• What is the breakup of the global biobanking
  market based on the specimen type?
• What is the breakup of the global biobanking
  market based on the biobank type?
• What is the breakup of the global biobanking
  market based on the application?
• What is the breakup of the global biobanking
  market based on the end user?
• What are the key regions in the global biobanking
  market?
• Who are the key players/companies in the global
  biobanking market?
•  

9
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Biobanking Market   
5.1    Market Overview    5.2    Market
Performance    5.3    Impact of COVID-19    5.4
   Market Forecast

10
Table of Contents
Report Description
6    Market Breakup by Specimen Type    6.1  
 Blood Products        6.1.1 Market Trends     
  6.1.2 Market Forecast    6.2    Solid Tissue 
      6.2.1 Market Trends        6.2.2 Market
Forecast    6.3    Cell Lines        6.3.1
Market Trends        6.3.2 Market Forecast   
6.4    Nucleic Acid        6.4.1 Market Trends 
      6.4.2 Market Forecast    6.5    Others   
    6.5.1 Market Trends        6.5.2 Market
Forecast          Click here to visit the
complete table of content with list of figures
and tables https//www.imarcgroup.com/biobanking-
market/toc

11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
14

Contact Us